We do not request reimbursement of costs
(such as repayment for obtaining medical records)
from veterans nor from people who suffer from multiple sclerosis.
Bronchiectasis can sometimes qualify as a disability under Social Security Administration rules, but a diagnosis alone rarely leads to approval.
The SSA evaluates bronchiectasis under its respiratory disorders listing, and a favorable decision typically depends on imaging evidence, pulmonary function results, and a documented pattern of hospitalizations tied to lung infections.
Applicants whose condition does not meet the strict medical listing may still be approved by showing that their breathing limitations prevent them from sustaining full-time work.
Bronchiectasis is a chronic lung disease in which the walls of the bronchial tubes become permanently widened and scarred. This damage allows mucus to pool inside the airways instead of draining normally, creating a cycle of infection, inflammation, and further lung damage.
The condition can develop after severe childhood pneumonia, from cystic fibrosis, from immune system disorders, or from autoimmune and inflammatory diseases such as rheumatoid arthritis. And in some cases, no clear cause is ever identified. In those cases, doctors typically call the condition idiopathic bronchiectasis.
Because the airway damage is permanent, bronchiectasis tends to worsen gradually over time, even with consistent treatment. Unfortunately, periods of relative stability are often interrupted by acute flare-ups that require aggressive antibiotic therapy or hospitalization.
Bronchiectasis is specifically named in the Social Security Administration’s Listing of Impairments, so applicants may not need to argue that their condition is equivalent to a listed disease.
The agency’s official respiratory disorders listing sets out the medical evidence that’s generally required to establish disability, including imaging that confirms airway dilation, along with the pulmonary function or hospitalization records that demonstrate how severely the condition limits breathing.
Because bronchiectasis is recognized within Section 3.00 of the Blue Book, many applicants find it useful to first understand the broader process of pursuing Social Security Disability Benefits, as the same rules on medical evidence, work history, and appeals generally apply to respiratory claims regardless of which specific lung condition is at issue.
The SSA generally evaluates bronchiectasis under one of two related listings, depending on how the condition presents and how well it is documented.
Imaging is required under either pathway. A CT scan or comparable study showing irreversible bronchial widening is the evidence that anchors the claim, since symptoms alone are not sufficient for the SSA to confirm the diagnosis or evaluate its severity.
Many applicants have bronchiectasis that is genuinely disabling but does not produce the exact test results or hospitalization pattern the listings require.
In these cases, the SSA moves to a residual functional capacity assessment, weighing how fatigue, supplemental oxygen use, frequent coughing, and missed workdays limit the applicant’s ability to sustain full-time employment, sometimes even in claims involving secondary bronchiectasis linked to an underlying autoimmune disease.
Age, education, and the physical demands of an applicant’s past jobs all factor into this analysis, which is why two people with nearly identical pulmonary function results can receive different outcomes.
Reviewing recent disability approval and denial trends can help applicants understand how often respiratory claims succeed through this second pathway rather than through a listing match.
Even outside of active flare-ups, bronchiectasis can make a normal workday difficult. Frequent coughing spells interrupt concentration, chronic fatigue reduces stamina over an eight-hour shift, and exposure to dust, fumes, or cold air at many job sites can trigger symptoms.
Applicants who require supplemental oxygen or frequent breaks for airway clearance therapy often find that these accommodations are incompatible with full-time work in physically demanding or public-facing roles, which is part of why vocational factors, not just medical test results, matter so much once a claim reaches the residual functional capacity stage.
Bronchiectasis rarely exists in isolation, and the SSA frequently evaluates it alongside related lung diseases that share overlapping symptoms and evaluation criteria.
Cystic fibrosis, a common childhood cause of bronchiectasis, is evaluated under its own dedicated listing rather than the general respiratory criteria, which can change the documentation an applicant needs to gather.
Chronic obstructive pulmonary disease claims are evaluated under the same general listing as bronchiectasis, and many long-term smokers develop both conditions together, which can complicate pulmonary function testing and make it harder to isolate which disease is driving a particular test result.
Applicants sometimes confuse bronchiectasis with emphysema and other obstructive lung diseases, but the two involve different physical changes in the lungs even though they share the same SSA listing pathway.
In rarer cases, traction bronchiectasis develops as a complication of sarcoidosis, a granulomatous lung disease that can scar and distort lung tissue over time.
A similar pattern can occur with pulmonary fibrosis disability claims, since progressive scarring from that condition can also pull and distort the surrounding airways.
Claims are often denied when imaging is missing or outdated, when hospitalization records don’t clearly connect the admission to a bronchiectasis exacerbation, or when treatment gaps suggest the condition isn’t being actively managed.
Disputes sometimes arise over whether telehealth pulmonology visits count as ongoing treatment for these purposes, particularly in rural areas where in-person specialist care is limited.
Applicants who are unsure why a claim was rejected can review answers to common Social Security Disability questions before deciding whether to appeal, since many denials are overturned once additional medical evidence is submitted.
Bronchiectasis can be a difficult condition to document for SSDI purposes, since it often waxes and wanes between flare-ups and periods of relative stability.
An experienced legal team can help gather the imaging, pulmonary testing, and hospitalization records the SSA typically expects to see, and can identify whether a claim is better suited to a listing match or a residual functional capacity argument.
Chermol & Fishman represents disability applicants with respiratory conditions nationwide, with offices in Pennsylvania, New Jersey, Texas, Florida, and Kentucky, and can review your medical records to help determine the strongest path forward for your specific diagnosis and work history.
Because bronchiectasis claims often hinge on details that are easy to overlook, such as the exact wording of a hospital discharge summary or whether a pulmonary function test was administered under medically stable conditions, an early records review can catch problems before they turn into a denial.
Bronchiectasis involves permanent, irreversible airway damage, but that alone doesn't guarantee SSDI approval. The SSA still requires medical evidence showing the condition meets a listing or significantly limits your ability to work on a sustained basis.
While hospitalization history can strengthen a claim under Listings 3.02 and 3.07, applicants may also qualify through pulmonary function testing results or a residual functional capacity assessment that doesn't depend on hospital admissions at all.
Imaging, including a CT scan, is often required to confirm the diagnosis. Depending on the listing pathway, spirometry, diffusing capacity testing, arterial blood gas studies, or pulse oximetry may also be needed to document severity.
Children with severe bronchiectasis, often tied to cystic fibrosis or an underlying immune disorder, may qualify for Supplemental Security Income under separate childhood bronchiectasis and cystic fibrosis-related SSI criteria that use similar but age-adjusted standards.
Bronchiectasis itself is not on the SSA's Compassionate Allowances list, though certain underlying causes, such as some genetic or immune disorders, may separately qualify for expedited review of the claim.
Initial decisions typically take three to five months, though timelines vary by state and by how complete the medical evidence is when the claim is first filed with the local field office.
Limited part-time work may be possible under the SSA's substantial gainful activity rules, but earning above the monthly threshold can jeopardize ongoing benefits, so it's worth discussing specific income limits with an attorney beforehand.
Denied applicants can request reconsideration and, if needed, a hearing before an administrative law judge. Many successful bronchiectasis claims are approved only after additional medical evidence is submitted at this later stage.